Efficacité et danger de l'interféron alpha dans le traitement des hémangiomes graves du nourrisson
- 29 February 2000
- journal article
- case report
- Published by Elsevier in Archives de Pédiatrie
- Vol. 7 (2) , 163-167
- https://doi.org/10.1016/s0929-693x(00)88087-2
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Guidelines of care for hemangiomas of infancyJournal of the American Academy of Dermatology, 1997
- Additional Corrections: Interferon for Hemangiomas of InfancyNew England Journal of Medicine, 1995
- Interferon Alfa-2b Therapy for Life-Threatening Hemangiomas of InfancyNew England Journal of Medicine, 1994
- Serious childhood angiomas: unsuccessful alpha-2b interferon treatment. A report of four casesBritish Journal of Dermatology, 1993
- Neurotoxicity of interferon-αAnti-Cancer Drugs, 1992
- Interferon Alfa-2a Therapy for Life-Threatening Hemangiomas of InfancyNew England Journal of Medicine, 1992
- TREATMENT OF HAEMANGIOENDOTHELIOMAS WITH ALPHA INTERFERONThe Lancet, 1989
- Treatment of Pulmonary Hemangiomatosis with Recombinant Interferon Alfa-2aNew England Journal of Medicine, 1989
- Successful Treatment of an Angiogenic DiseaseNew England Journal of Medicine, 1989
- Neurologic Sequelae Following Interferon Therapy of Juvenile Laryngeal PapillomaActa Paediatrica, 1988